Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5QQB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,918
Award facts
- Contract value 100% obligated
- $24,917.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,917.51 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, making this procurement consistent with the Defense Health Agency's pharmaceutical supply needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen has demonstrated consistent capability to fulfill federal procurement requirements across multiple therapeutic domains through competitive contract awards with the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F5QQB?
SPE2DR26F5QQB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F5QQB worth?
The government has obligated $24,918 on SPE2DR26F5QQB.
Is contract SPE2DR26F5QQB an order under another contract?
Yes. SPE2DR26F5QQB is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QQB competed?
The extent of competition for SPE2DR26F5QQB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award